Citation Impact
Citing Papers
Effective Photothermal Chemotherapy Using Doxorubicin-Loaded Gold Nanospheres That Target EphB4 Receptors in Tumors
2012
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
2019 Standout
Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States
2017
TOR Signaling in Growth and Metabolism
2006 Standout
Cancer statistics, 2023
2023 Standout
Progress and challenges towards targeted delivery of cancer therapeutics
2018 Standout
Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells
2008
RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells
2010
mTOR signaling: implications for cancer and anticancer therapy
2005
Hallmarks of Cancer: The Next Generation
2011 Standout
Triple-Negative Breast Cancer
2010 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
2014 Standout
mTOR Signaling in Growth Control and Disease
2012 Standout
A view on drug resistance in cancer
2019 StandoutNature
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
A Mechanical Checkpoint Controls Multicellular Growth through YAP/TAZ Regulation by Actin-Processing Factors
2013 Standout
Strategies for minimizing complications of neutropenia: Prophylactic myeloid growth factors or antibiotics
2009
The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer
2008 StandoutNobel
Recent progress on semiconducting polymer nanoparticles for molecular imaging and cancer phototherapy
2017
Targeted Therapy for Breast Cancer
2013
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Gastrointestinal stromal tumour
2007
Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy
2011
The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus
2013
Targeting 14-3-3zeta in cancer therapy
2011
Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed
2016
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
2019 Standout
Global Proteome Analysis of the NCI-60 Cell Line Panel
2013
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics
2016
Stimuli-responsive nanocarriers for drug delivery
2013 Standout
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
2005 Standout
Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer
2010
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
Colorectal cancer
2019 Standout
The Farnesyl Transferase Inhibitor (FTI) SCH66336 (lonafarnib) Inhibits Rheb Farnesylation and mTOR Signaling
2005
miRNA–target chimeras reveal miRNA 3′-end pairing as a major determinant of Argonaute target specificity
2015 StandoutNobel
Type 2 diabetes
2017 Standout
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
2009 StandoutNature
On the Dependency of Cellular Protein Levels on mRNA Abundance
2016 Standout
Molecular activity of sirolimus and its possible application in tuberous sclerosis treatment
2005
Consensus Guidelines for the Management of Postoperative Nausea and Vomiting
2013 Standout
Tuberous sclerosis
2008 Standout
Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors
2008
Hindlimb Suspension and SPE-Like Radiation Impairs Clearance of Bacterial Infections
2014 StandoutNobel
Emerging Biological Principles of Metastasis
2017 Standout
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
2017 Standout
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
Targeting metastasis
2016
Possibilities and limitations in the pharmacological management of postoperative nausea and vomiting
2011
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Rising Proportion of Young Individuals With Rectal and Colon Cancer
2018
The Hippo pathway and human cancer
2013
The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease
2018 Standout
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
2011 Standout
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
Inflammation and cancer: how friendly is the relationship for cancer patients?
2009
Metformin—mode of action and clinical implications for diabetes and cancer
2014
Environment Dictates Dependence on Mitochondrial Complex I for NAD+ and Aspartate Production and Determines Cancer Cell Sensitivity to Metformin
2016
Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion
2015
Biomarker-driven and molecular targeted therapies for colorectal cancers
2017
Endothelial Akt Signaling Is Rate-Limiting for Rapamycin Inhibition of Mouse Mammary Tumor Progression
2007
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Targeting the mTOR Signaling Network for Cancer Therapy
2009
Screening for Colorectal Cancer
2016 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Breast Cancer Treatment
2019 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600–Mutant Colorectal Cancer
2015
Colorectal cancer statistics, 2017
2017 Standout
Estimation of the Number of Individuals Living With Metastatic Cancer in the United States
2022
DNA origami protection and molecular interfacing through engineered sequence-defined peptoids
2020 StandoutNobel
Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline
2013
Integrating Systemic Therapies into the Multimodality Treatment of Resectable Colorectal Liver Metastases
2018
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Roles for Growth Factors in Cancer Progression
2010
MicroRNAs in Human Malignant Gliomas
2012
Programmable and Multifunctional DNA‐Based Materials for Biomedical Applications
2018
Microsatellite Instability as a Biomarker for PD-1 Blockade
2016
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Tumor Microenvironment‐Triggered Supramolecular System as an In Situ Nanotheranostic Generator for Cancer Phototherapy
2017
Works of Joe Ensor being referenced
14-3-3ζ Overexpression Defines High Risk for Breast Cancer Recurrence and Promotes Cancer Cell Survival
2009
Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer
2011
Phase I/II Study of Trastuzumab in Combination With Everolimus (RAD001) in Patients With HER2-Overexpressing Metastatic Breast Cancer Who Progressed on Trastuzumab-Based Therapy
2011
Effects of Near-infrared Laser Irradiation of Biodegradable Microspheres Containing Hollow Gold Nanospheres and Paclitaxel Administered Intraarterially in a Rabbit Liver Tumor Model
2012
Hepatic artery chemoembolization for 110 gastrointestinal stromal tumors
2006
Hepatic Arterial Embolization and Chemoembolization in the Management of Patients with Large-Volume Liver Metastases
2007
An injectable nanoparticle generator enhances delivery of cancer therapeutics
2016
Tumor Uptake of Hollow Gold Nanospheres After Intravenous and Intra-arterial Injection: PET/CT Study in a Rabbit VX2 Liver Cancer Model
2013
Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H)
2014
Ongoing Provision of Individual Clinician Performance Data Improves Practice Behavior
2010
14-3-3ζ Turns TGF-β’s Function from Tumor Suppressor to Metastasis Promoter in Breast Cancer by Contextual Changes of Smad Partners from p53 to Gli2
2015
Impact of C-arm CT on Hepatic Arterial Interventions for Hepatic Malignancies
2007
Meta-analyses of colorectal cancer risk factors
2013
MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers
2008
Survival differences among women with de novo stage IV and relapsed breast cancer
2010
Targeting Mammalian Target of Rapamycin Synergistically Enhances Chemotherapy-Induced Cytotoxicity in Breast Cancer Cells
2004
Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin
2016
Pretherapy nuclear factor-κB status, chemoradiation resistance, and metastatic progression in esophageal carcinoma
2006
Outcomes and Cost of Outpatient or Inpatient Management of 712 Patients With Febrile Neutropenia
2008
Association of Activated Transcription Factor Nuclear Factor κB With Chemoradiation Resistance and Poor Outcome in Esophageal Carcinoma
2006